Panobinostat Lactate Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 10 mg, 15 mg, 20 mg
Reference Brands: Farydak (USA/EU),
Category: Oncology Cancer Care
Panobinostat Lactate is a Oncology Cancer Care product available as Capsules in strengths 10 mg, 15 mg, 20 mg. It corresponds to the reference brands Farydak (USA/EU),. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Panobinostat is a targeted anticancer medication that belongs to a class of drugs known as histone deacetylase (HDAC) inhibitors. It is used in the treatment of certain cancers and has shown particular effectiveness in patients with multiple myeloma who have received prior therapies. Panobinostat works by inhibiting HDAC enzymes, which play an important role in regulating gene expression within cells. By blocking these enzymes, the drug causes hyperacetylation of histones and other intracellular proteins, allowing the activation of genes that can suppress tumor growth.
Through this mechanism, Panobinostat helps inhibit the proliferation of cancer cells and promotes programmed cell death, also known as apoptosis. In addition to affecting gene expression, the drug can also trigger cellular death receptor pathways, further contributing to the destruction of malignant cells. Preclinical and clinical studies have demonstrated that Panobinostat is a highly potent HDAC inhibitor, showing strong anticancer activity even at very low concentrations.
Panobinostat has been evaluated in both oral and intravenous formulations across various tumor types and continues to be studied for its potential role in treating solid tumors and other hematologic malignancies. It is marketed under the brand name Farydak and represents an important advancement in targeted cancer therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Panobinostat lactate is used for the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. It is typically prescribed in combination with other medicines such as bortezomib and dexamethasone in patients who have previously received at least two prior therapies.
Panobinostat lactate is a synthetic small-molecule anticancer drug that works by inhibiting histone deacetylase (HDAC) enzymes. By blocking these enzymes, the medicine interferes with cancer cell growth, induces cell cycle arrest, and promotes apoptosis (programmed cell death) in malignant cells.
The main trade name of Panobinostat lactate is Farydak.
Panobinostat lactate is developed and marketed by Novartis.
The generic name of the medicine sold under the brand Farydak is Panobinostat lactate.
The primary brand name of Panobinostat lactate is Farydak.
Panobinostat lactate is manufactured at GMP-certified pharmaceutical facilities operated or authorized by Novartis and its global manufacturing partners, following regulatory standards set by agencies such as the US FDA and the European Medicines Agency.
Related Products
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View DetailsGilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsIdelalisib
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Zydelig (EU/UK/India)
View DetailsInotuzumab Ozogamicin
Strength:
1 mg
Form: Injection
Reference Brands: Besponsa (USA/LATAM)
View DetailsQuick Response Guaranteed | Verified Suppliers